Skip to main content
. 2022 Aug 22;10:979330. doi: 10.3389/fcell.2022.979330

TABLE 2.

Primary antibodies used in the study.

Target Type Company Dilution
TOMM20 monoclonal Abcam, Cambridge UK 1:200
UCP1 monoclonal Cell Signaling, Danvers MA, United States 1:1000
TBX1 polyclonal GeneTex, Irvine, CA, United States 1:500
PGC1a polyclonal Thermo Fisher Scientific, Waltham, MA, United States 1:1000 for WB
1:200 for IP
acetyl-lysine antibody polyclonal Cell Signaling, Danvers MA, United States 1:500
Poly (ADP-ribose) (10H) monoclonal Sigma aldrich 1:500
Mono(ADP-ribose) monoclonal Sigma aldrich 1:1000
β-Actin−Peroxidase polyclonal Sigma aldrich 1:20000